Nuveen, LLC Annexon, Inc. Transaction History
Nuveen, LLC
- $363 Billion
- Q3 2025
A detailed history of Nuveen, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 682,558 shares of ANNX stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
682,558
Previous 255,918
166.71%
Holding current value
$1.95 Million
Previous $614,000
231.27%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
101MCall Options Held
88.6KPut Options Held
32.5K-
Satter Management Co., L.P.7.41MShares$21.2 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$20 Million1.13% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$18 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.84MShares$16.7 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $136M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...